Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology

被引:1
作者
Goedicke, Swenja [1 ,2 ]
Kresbach, Catena [1 ,2 ,3 ]
Ehlert, Max [1 ,2 ]
Obrecht, Denise [1 ]
Altendorf, Lea [1 ,2 ]
Hack, Karoline [1 ,2 ]
von Hoff, Katja [4 ,5 ,6 ]
Caren, Helena [7 ]
Melcher, Viktoria [8 ]
Kerl, Kornelius [8 ]
Englinger, Bernhard [9 ,10 ,11 ,12 ,13 ]
Filbin, Mariella [9 ,10 ]
Pajtler, Kristian W. [14 ,15 ,16 ]
Gojo, Johannes [17 ,18 ]
Pietsch, Torsten [19 ]
Rutkowski, Stefan [1 ]
Schueller, Ulrich [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany
[2] Res Inst Childrens Canc Ctr, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Martinistr 52, D-20246 Hamburg, Germany
[4] Charite Univ Med Berlin, Dept Pediat Oncol & Hematol, Berlin, Germany
[5] Free Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth, Berlin, Germany
[6] Aarhus Univ Hosp, Dept Pediat & Adolescent Med, Aarhus, Denmark
[7] Univ Gothenburg, Sahlgrenska Ctr Canc Res, Dept Lab Med, Inst Biomed,Sahlgrenska Acad, Gothenburg, Sweden
[8] Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany
[9] Dana Farber Boston Childrens Canc & Blood Disorder, Dept Pediat Oncol, Boston, MA 02115 USA
[10] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA
[11] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, A-1090 Vienna, Austria
[12] Med Univ Vienna, Ctr Canc Res, A-1090 Vienna, Austria
[13] Med Univ Vienna, Comprehens Canc Ctr, A-1090 Vienna, Austria
[14] Hopp Childrens Canc Ctr Heidelberg KiTZ, D-69120 Heidelberg, Germany
[15] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Div Pediat Neurooncol, D-69120 Heidelberg, Germany
[16] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany
[17] Med Univ Vienna, Dept Pediat & Adolescent Med, Comprehens Ctr Pediat, Vienna, Austria
[18] Med Univ Vienna, Comprehens Canc Ctr, A-1090 Vienna, Austria
[19] Univ Bonn, Med Ctr, Inst Neuropathol, DGNN Brain Tumor Reference Ctr, Bonn, Germany
关键词
Ependymoma; Intratumoral heterogeneity; 1q gain; 6q loss; Morphology; DNA methylation; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; CANCER; CLASSIFICATION; MIDKINE; PROGRESSION; RNA;
D O I
10.1007/s00401-023-02682-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Posterior fossa type A (PF-EPN-A, PFA) ependymoma are aggressive tumors that mainly affect children and have a poor prognosis. Histopathology shows significant intratumoral heterogeneity, ranging from loose tissue to often sharply demarcated, extremely cell-dense tumor areas. To determine molecular differences in morphologically different areas and to understand their clinical significance, we analyzed 113 PF-EPN-A samples, including 40 corresponding relapse samples. Cell-dense areas ranged from 0 to 100% of the tumor area and displayed a higher proportion of proliferating tumor cells (p < 0.01). Clinically, cell density was associated with poor progression-free and overall survival (pPFS = 0.0026, pOS < 0.01). Molecularly, tumor areas with low and high cell density showed diverging DNA methylation profiles regarding their similarity to distinct previously discovered PF-EPN-A subtypes in 9/21 cases. Prognostically relevant chromosomal changes at 1q and 6q showed spatial heterogeneity within single tumors and were significantly enriched in cell-dense tumor areas as shown by single-cell RNA (scRNA)-sequencing as well as copy number profiling and fluorescence in situ hybridization (FISH) analyses of different tumor areas. Finally, spatial transcriptomics revealed cell-dense areas of different tumors to be more similar than various different areas of the same tumor. High-density areas distinctly overexpressed genes encoding histone proteins, WNT5A, TGFB1, or IGF2. Relapsing tumors displayed a higher proportion of cell-dense areas (p = 0.036), a change in PF-EPN-A methylation subtypes (13/32 patients), and novel chromosome 1q gains and 6q losses (12/32 cases) compared to corresponding primary tumors. Our data suggest that PF-EPN-A ependymomas habor a previously unrecognized intratumoral heterogeneity with clinical implications, which has to be accounted for when selecting diagnostic material, inter alia, by histological evaluation of the proportion of cell-dense areas.
引用
收藏
页数:16
相关论文
共 47 条
  • [31] The role of the IGF system in cancer: From basic to clinical studies and clinical applications
    Moschos, SJ
    Mantzoros, CS
    [J]. ONCOLOGY, 2002, 63 (04) : 317 - 332
  • [32] Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
    Muramatsu, Takashi
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (05) : 410 - 423
  • [33] EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations
    Nambirajan, Aruna
    Sharma, Agrima
    Rajeshwari, Madhu
    Boorgula, Meher Tej
    Doddamani, Ramesh
    Garg, Ajay
    Suri, Vaishali
    Sarkar, Chitra
    Sharma, Mehar
    [J]. BRAIN TUMOR PATHOLOGY, 2021, 38 (01) : 30 - 40
  • [34] Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
    Pajtler, Kristian W.
    Wen, Ji
    Sill, Martin
    Lin, Tong
    Orisme, Wilda
    Tang, Bo
    Huebner, Jens-Martin
    Ramaswamy, Vijay
    Jia, Sujuan
    Dalton, James D.
    Haupfear, Kelly
    Rogers, Hazel A.
    Punchihewa, Chandanamali
    Lee, Ryan
    Easton, John
    Wu, Gang
    Ritzmann, Timothy A.
    Chapman, Rebecca
    Chavez, Lukas
    Boop, Fredrick A.
    Klimo, Paul
    Sabin, Noah D.
    Ogg, Robert
    Mack, Stephen C.
    Freibaum, Brian D.
    Kim, Hong Joo
    Witt, Hendrik
    Jones, David T. W.
    Vo, Baohan
    Gajjar, Amar
    Pounds, Stan
    Onar-Thomas, Arzu
    Roussel, Martine F.
    Zhang, Jinghui
    Taylor, J. Paul
    Merchant, Thomas E.
    Grundy, Richard
    Tatevossian, Ruth G.
    Taylor, Michael D.
    Pfister, Stefan M.
    Korshunov, Andrey
    Kool, Marcel
    Ellison, David W.
    [J]. ACTA NEUROPATHOLOGICA, 2018, 136 (02) : 211 - 226
  • [35] Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
    Pajtler, Kristian W.
    Witt, Hendrik
    Sill, Martin
    Jones, David T. W.
    Hovestadt, Volker
    Kratochwil, Fabian
    Wani, Khalida
    Tatevossian, Ruth
    Punchihewa, Chandanamali
    Johann, Pascal
    Reimand, Jueri
    Warnatz, Hans-Joerg
    Ryzhova, Marina
    Mack, Steve
    Ramaswamy, Vijay
    Capper, David
    Schweizer, Leonille
    Sieber, Laura
    Wittmann, Andrea
    Huang, Zhiqin
    van Sluis, Peter
    Volckmann, Richard
    Koster, Jan
    Versteeg, Rogier
    Fults, Daniel
    Toledano, Helen
    Avigad, Smadar
    Hoffman, Lindsey M.
    Donson, Andrew M.
    Foreman, Nicholas
    Hewer, Ekkehard
    Zitterbart, Karel
    Gilbert, Mark
    Armstrong, Terri S.
    Gupta, Nalin
    Allen, Jeffrey C.
    Karajannis, Matthias A.
    Zagzag, David
    Hasselblatt, Martin
    Kulozik, Andreas E.
    Witt, Olaf
    Collins, V. Peter
    von Hoff, Katja
    Rutkowski, Stefan
    Pietsch, Torsten
    Bader, Gary
    Yaspo, Marie-Laure
    von Deimling, Andreas
    Lichter, Peter
    Taylor, Michael D.
    [J]. CANCER CELL, 2015, 27 (05) : 728 - 743
  • [36] C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma
    Parker, Matthew
    Mohankumar, Kumarasamypet M.
    Punchihewa, Chandanamali
    Weinlich, Ricardo
    Dalton, James D.
    Li, Yongjin
    Lee, Ryan
    Tatevossian, Ruth G.
    Phoenix, Timothy N.
    Thiruvenkatam, Radhika
    White, Elsie
    Tang, Bo
    Orisme, Wilda
    Gupta, Kirti
    Rusch, Michael
    Chen, Xiang
    Li, Yuxin
    Nagahawhatte, Panduka
    Hedlund, Erin
    Finkelstein, David
    Wu, Gang
    Shurtleff, Sheila
    Easton, John
    Boggs, Kristy
    Yergeau, Donald
    Vadodaria, Bhavin
    Mulder, Heather L.
    Becksford, Jared
    Gupta, Pankaj
    Huether, Robert
    Ma, Jing
    Song, Guangchun
    Gajjar, Amar
    Merchant, Thomas
    Boop, Frederick
    Smith, Amy A.
    Ding, Li
    Lu, Charles
    Ochoa, Kerri
    Zhao, David
    Fulton, Robert S.
    Fulton, Lucinda L.
    Mardis, Elaine R.
    Wilson, Richard K.
    Downing, James R.
    Green, Douglas R.
    Zhang, Jinghui
    Ellison, David W.
    Gilbertson, Richard J.
    [J]. NATURE, 2014, 506 (7489) : 451 - +
  • [37] TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling
    Peng, Peng
    Zhu, Hongtao
    Liu, Dan
    Chen, Zirong
    Zhang, Xiaolin
    Guo, Zhongyin
    Dong, Minhai
    Wan, Lijun
    Zhang, Po
    Liu, Guohao
    Zhang, Suojun
    Dong, Fangyong
    Hu, Feng
    Cheng, Fangling
    Huang, Shijun
    Guo, Dongsheng
    Zhang, Bin
    Yu, Xingjiang
    Wan, Feng
    [J]. THERANOSTICS, 2022, 12 (09): : 4221 - 4236
  • [38] Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
    Pun, Matthew
    Pratt, Drew
    Nano, Patricia R.
    Joshi, Piyush K.
    Jiang, Li
    Englinger, Bernhard
    Rao, Arvind
    Cieslik, Marcin
    Chinnaiyan, Arul M.
    Aldape, Kenneth
    Pfister, Stefan
    Filbin, Mariella G.
    Bhaduri, Aparna
    Venneti, Sriram
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [39] High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
    Raffeld, Mark
    Abdullaev, Zied
    Pack, Svetlana D.
    Xi, Liqiang
    Nagaraj, Sushma
    Briceno, Nicole
    Vera, Elizabeth
    Pittaluga, Stefania
    Lopes Abath Neto, Osorio
    Quezado, Martha
    Aldape, Kenneth
    Armstrong, Terri S.
    Gilbert, Mark R.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [40] Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
    Ramaswamy, Vijay
    Hielscher, Thomas
    Mack, Stephen C.
    Lassaletta, Alvaro
    Lin, Tong
    Pajtler, Kristian W.
    Jones, David T. W.
    Luu, Betty
    Cavalli, Florence M. G.
    Aldape, Kenneth
    Remke, Marc
    Mynarek, Martin
    Rutkowski, Stefan
    Gururangan, Sridharan
    McLendon, Roger E.
    Lipp, Eric S.
    Dunham, Christopher
    Hukin, Juliette
    Eisenstat, David D.
    Fulton, Dorcas
    van Landeghem, Frank K. H.
    Santi, Mariarita
    van Veelen, Marie-Lise C.
    Van Meir, Erwin G.
    Osuka, Satoru
    Fan, Xing
    Muraszko, Karin M.
    Tirapelli, Daniela P. C.
    Oba-Shinjo, Sueli M.
    Marie, Suely K. N.
    Carlotti, Carlos G.
    Lee, Ji Yeoun
    Rao, Amulya A. Nageswara
    Giannini, Caterina
    Faria, Claudia C.
    Nunes, Sofia
    Mora, Jaume
    Hamilton, Ronald L.
    Hauser, Peter
    Jabado, Nada
    Petrecca, Kevin
    Jung, Shin
    Massimi, Luca
    Zollo, Massimo
    Cinalli, Giuseppe
    Bognar, Laszlo
    Klekner, Almos
    Hortobagyi, Tibor
    Leary, Sarah
    Ermoian, Ralph P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (21) : 2468 - +